MA27118A1 - Derives de benzoxazine servant de modulateurs de 5-ht6 et leurs utilisations - Google Patents

Derives de benzoxazine servant de modulateurs de 5-ht6 et leurs utilisations

Info

Publication number
MA27118A1
MA27118A1 MA27944A MA27944A MA27118A1 MA 27118 A1 MA27118 A1 MA 27118A1 MA 27944 A MA27944 A MA 27944A MA 27944 A MA27944 A MA 27944A MA 27118 A1 MA27118 A1 MA 27118A1
Authority
MA
Morocco
Prior art keywords
modulators
benzoxazine derivatives
benzoxazine
derivatives
Prior art date
Application number
MA27944A
Other languages
English (en)
Inventor
Jacob Berger
Robin Douglas Clark
Shu-Hai Zhao
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MA27118A1 publication Critical patent/MA27118A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA27944A 2002-05-13 2004-11-12 Derives de benzoxazine servant de modulateurs de 5-ht6 et leurs utilisations MA27118A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37800302P 2002-05-13 2002-05-13

Publications (1)

Publication Number Publication Date
MA27118A1 true MA27118A1 (fr) 2004-12-20

Family

ID=29420358

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27944A MA27118A1 (fr) 2002-05-13 2004-11-12 Derives de benzoxazine servant de modulateurs de 5-ht6 et leurs utilisations

Country Status (37)

Country Link
US (4) US6867204B2 (fr)
EP (1) EP1506179B1 (fr)
JP (1) JP4307377B2 (fr)
KR (1) KR100636475B1 (fr)
CN (1) CN100429206C (fr)
AR (1) AR039988A1 (fr)
AT (1) ATE316523T1 (fr)
AU (1) AU2003233231B2 (fr)
BR (1) BRPI0310032B8 (fr)
CA (1) CA2485136C (fr)
DE (1) DE60303376T2 (fr)
DK (1) DK1506179T3 (fr)
EA (1) EA009982B1 (fr)
EC (1) ECSP045420A (fr)
EG (1) EG25683A (fr)
ES (1) ES2256744T3 (fr)
GT (1) GT200300108A (fr)
HK (1) HK1080846A1 (fr)
HR (1) HRP20041030B1 (fr)
IL (1) IL164928A0 (fr)
JO (1) JO2413B1 (fr)
MA (1) MA27118A1 (fr)
MX (1) MXPA04011254A (fr)
MY (1) MY139612A (fr)
NO (1) NO329380B1 (fr)
NZ (1) NZ536230A (fr)
PA (1) PA8573501A1 (fr)
PE (1) PE20040757A1 (fr)
PL (1) PL211057B1 (fr)
PT (1) PT1506179E (fr)
RS (1) RS51042B (fr)
TN (1) TNSN04225A1 (fr)
TW (1) TWI258479B (fr)
UA (1) UA76877C2 (fr)
UY (1) UY27803A1 (fr)
WO (1) WO2003095434A1 (fr)
ZA (1) ZA200408783B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003007956A1 (fr) 2001-07-20 2003-01-30 Psychogenics, Inc. Traitement des troubles de deficit de l'attention/hyperactivite
JP4455064B2 (ja) 2002-03-27 2010-04-21 グラクソ グループ リミテッド キノリン誘導体および５−ｈｔ６リガンドとしてのその使用
PL211057B1 (pl) * 2002-05-13 2012-04-30 Hoffmann La Roche Pochodne benzoksazyny, sposób ich wytwarzania, środek farmaceutyczny i zastosowanie pochodnych benzoksazyny
RU2328490C2 (ru) * 2002-11-08 2008-07-10 Ф.Хоффманн-Ля Рош Аг Производные бензоксазинонов и фармацевтическая композиция на их основе
CA2533369C (fr) 2003-07-22 2009-07-14 Arena Pharmaceuticals, Inc. Derives de diaryl et arylheteroaryl uree utilises en tant que modulateurs du recepteur de la serotonine 5-ht2a utiles pour la prophylaxie et le traitement de troubles associes a ce dernier
KR100827915B1 (ko) * 2003-12-09 2008-05-07 에프. 호프만-라 로슈 아게 벤즈옥사진 유도체 및 그의 용도
KR100843053B1 (ko) * 2004-01-16 2008-07-01 에프. 호프만-라 로슈 아게 중추 신경계 질환의 치료를 위한 5-하이드록시트립트아민수용체(5-ｈｔ)의 조절제로서1-벤질-5-피페라진-1-일-3,4-다이하이드로-1ｈ-퀴나졸린-2-온 유도체 및 각각의1ｈ-벤조(1,2,6)티아다이아진-2,2-다이옥사이드 및1,4-다이하이드로-벤조(ｄ)(1,3)옥사진-2-온 유도체
CA2566196A1 (fr) * 2004-05-05 2005-11-10 F. Hoffmann-La Roche Ag Arylsulfonyl benzodioxanes servant a moduler les recepteurs 5-ht6 et 5-ht2a ou les deux
US7378415B2 (en) * 2004-09-30 2008-05-27 Roche Palo Alto Llc Benzoxazine and quinoxaline derivatives and uses thereof
US7713954B2 (en) * 2004-09-30 2010-05-11 Roche Palo Alto Llc Compositions and methods for treating cognitive disorders
DE602005022896D1 (de) * 2004-09-30 2010-09-23 Hoffmann La Roche Benzoxazin- und chinoxalinderivate und anwendungen
ES2359725T3 (es) * 2004-09-30 2011-05-26 F. Hoffmann-La Roche Ag Composiciones y métodos para el tratamiento de trastornos cognitivos.
EP2508177A1 (fr) 2007-12-12 2012-10-10 Glaxo Group Limited Associations contenant de la 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
WO2009123714A2 (fr) 2008-04-02 2009-10-08 Arena Pharmaceuticals, Inc. Procédés de préparation de dérivés de pyrazole utiles comme modulateurs du récepteur de la sérotonine 5-ht<sb>2a</sb>
WO2010062321A1 (fr) 2008-10-28 2010-06-03 Arena Pharmaceuticals, Inc. Procédés utiles pour la préparation de 1-[3-(4-bromo-2-méthyl-2h-pyrazol-3-yl)-4-méthoxy-phényl]-3-(2,4-difluoro‑phényl)-urée, et formes cristallines associées
AR078770A1 (es) * 2009-10-27 2011-11-30 Elara Pharmaceuticals Gmbh Derivados de dihidrobenzo oxacinas y tiazinas, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades inflamatorias e hiperproliferativas.
KR101293384B1 (ko) * 2010-10-13 2013-08-05 주식회사 대웅제약 신규 피리딜 벤조옥사진 유도체, 이를 포함하는 약학 조성물 및 이의 용도
US9403800B2 (en) * 2012-01-24 2016-08-02 Chemregen, Inc. Compounds for inhibition of cancer cell proliferation
US10087151B2 (en) 2014-01-09 2018-10-02 The J. David Gladstone Institutes, A Testimentary Trust Established Under The Will Of J. David Gladstone Substituted benzoxazine and related compounds
RU2017145976A (ru) 2015-06-12 2019-07-15 Аксовант Сайенсиз Гмбх Производные диарил- и арилгетероарилмочевины, применимые для профилактики и лечения нарушения поведения во время REM-фазы сна
JP2018520187A (ja) 2015-07-15 2018-07-26 アクソヴァント サイエンシーズ ゲゼルシャフト ミット ベシュレンクテル ハフツングAxovant Sciences GmbH 神経変性疾患と関連する幻覚の予防および処置のために有用な５−ｈｔ２ａセロトニン受容体のモジュレーターとしてのジアリールおよびアリールヘテロアリール尿素誘導体

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1029479C (zh) * 1989-11-08 1995-08-09 山之内制药株式会社 新型苯并噁嗪衍生物的制备方法
US5492914A (en) * 1994-07-28 1996-02-20 Syntex (U.S.A.) Inc. 2-(1-azabicyclo[2.2.2]oct-3 s-yl)-6-hydroxy-2,4,5,6-tetrahydro-1H-benz[DE]is[2.2.2]oct-3's-yl)-6-hydroxy-2,3,3a,4,5,6-hexahydro-1h-benz [DE]isoquinolin-1-one and individual stereoisomers thereof
GB9507203D0 (en) 1995-04-07 1995-05-31 Smithkline Beecham Plc Novel compounds
DZ2376A1 (fr) * 1996-12-19 2002-12-28 Smithkline Beecham Plc Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
BR9809092A (pt) 1997-04-18 2002-01-22 Smithkline Beecham Plc Derivados de indol tendo atividade combinada de antagonista de receptor de 5ht1a, 5ht1b e 5ht1d
EP0994862B1 (fr) 1997-07-11 2005-06-01 SmithKline Beecham plc Derives sulphonamide comme antagonistes du recepteur 5-ht6 et procede pour leur preparation
CA2297825C (fr) * 1997-07-25 2006-03-14 H. Lundbeck A/S Derives indole et 2,3-dihydro-indole, leur preparation et utilisation
GB9801392D0 (en) 1998-01-22 1998-03-18 Smithkline Beecham Plc Novel compounds
NZ508506A (en) * 1998-06-19 2004-01-30 H 4,5,6 and 7-indole and indoline derivatives, their preparation and use
GB9818916D0 (en) 1998-08-28 1998-10-21 Smithkline Beecham Plc Use
US6380235B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Benzimidazolones and analogues
SK287018B6 (sk) * 1999-08-23 2009-09-07 Solvay Pharmaceuticals B. V. Deriváty fenylpiperazínov, spôsob ich prípravy, farmaceutická kompozícia s ich obsahom a ich použitie
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
AU2001236606A1 (en) 2000-02-01 2001-08-14 Cor Therapeutics, Inc. 3,4-dihydro-2h-benzo(1,4)oxazine inhibitors of factor xa
PL211057B1 (pl) * 2002-05-13 2012-04-30 Hoffmann La Roche Pochodne benzoksazyny, sposób ich wytwarzania, środek farmaceutyczny i zastosowanie pochodnych benzoksazyny

Also Published As

Publication number Publication date
EG25683A (en) 2012-05-16
JP4307377B2 (ja) 2009-08-05
UY27803A1 (es) 2003-11-28
ECSP045420A (es) 2005-01-03
TW200400188A (en) 2004-01-01
MXPA04011254A (es) 2005-01-25
ES2256744T3 (es) 2006-07-16
US20130123251A1 (en) 2013-05-16
DE60303376T2 (de) 2006-11-16
MY139612A (en) 2009-10-30
NO20044665L (no) 2004-12-03
GT200300108A (es) 2004-03-15
KR20040106538A (ko) 2004-12-17
EA009982B1 (ru) 2008-04-28
ATE316523T1 (de) 2006-02-15
EP1506179A1 (fr) 2005-02-16
ZA200408783B (en) 2005-12-28
DE60303376D1 (de) 2006-04-13
PE20040757A1 (es) 2004-11-06
US20090325950A1 (en) 2009-12-31
UA76877C2 (uk) 2006-09-15
PA8573501A1 (es) 2003-12-10
CN1653054A (zh) 2005-08-10
DK1506179T3 (da) 2006-06-06
BRPI0310032B1 (pt) 2019-01-08
CN100429206C (zh) 2008-10-29
JP2005530774A (ja) 2005-10-13
NO329380B1 (no) 2010-10-04
PT1506179E (pt) 2006-06-30
KR100636475B1 (ko) 2006-10-18
HRP20041030A2 (en) 2005-06-30
IL164928A0 (en) 2005-12-18
CA2485136A1 (fr) 2003-11-20
TWI258479B (en) 2006-07-21
HRP20041030B1 (hr) 2013-03-31
CA2485136C (fr) 2011-12-20
TNSN04225A1 (fr) 2007-03-12
NZ536230A (en) 2007-05-31
US20050130962A1 (en) 2005-06-16
EP1506179B1 (fr) 2006-01-25
RS97004A (en) 2006-10-27
US20030232825A1 (en) 2003-12-18
EA200401455A1 (ru) 2005-06-30
BR0310032A (pt) 2005-02-15
US6867204B2 (en) 2005-03-15
AR039988A1 (es) 2005-03-09
AU2003233231A1 (en) 2003-11-11
HK1080846A1 (en) 2006-05-04
WO2003095434A1 (fr) 2003-11-20
PL211057B1 (pl) 2012-04-30
BRPI0310032B8 (pt) 2021-05-25
JO2413B1 (en) 2007-11-11
RS51042B (sr) 2010-10-31
PL374019A1 (en) 2005-09-19
US8377931B2 (en) 2013-02-19
AU2003233231B2 (en) 2009-02-26

Similar Documents

Publication Publication Date Title
MA27118A1 (fr) Derives de benzoxazine servant de modulateurs de 5-ht6 et leurs utilisations
MA27035A1 (fr) Ligands de recepteurs de 5-ht et leurs utilisations
DE60330098D1 (de) Hydroxyalkylstärke-Derivate
ATE478870T1 (de) Spiroindolinpiperidinderivate
DK1556385T3 (da) Heterocyclocarboxamid-derivater
DE60134338D1 (de) Piperazin-derivate
DK2248807T3 (da) N-Phenyl-2-pyrimidinaminderivater
DE60036053D1 (de) Erythropoietin Derivate
ITGE20020104A1 (it) Composizioni polimeriche rapidamente riscaldabili
NO20054135D0 (no) Kipolinon/benzoksazin derivater og anvendelser derav
DK1500654T3 (da) Benzoxazinonderivater, fremstilling deraf og anvendelse deraf som lægemidler
DE60306627D1 (de) Dynamisches sicherheitssystem
ATE362469T1 (de) 2,7-disubstituierteindole und ihre verwendung als 5-ht6 modulatoren
DE602004008668D1 (de) Benzoxazinderivate und deren verwendungen
ATE423771T1 (de) Tetrahydrochinolinderivate
NO20041984L (no) Stenter
DE60307918D1 (de) Rotationsdämpfer
MA28811B1 (fr) Nouvelles utilisations de derives d&#39;imidazotriazinones substituees par 2-phenyle
DE60114039D1 (de) Kautschukzusammensetzungen und vulkanisate einschliesslich verzweigter kammpolymere
FR2886846B1 (fr) Nouvelles utilisations de derives du glycerol, notamment dans le domaine cosmetique
NO20026104D0 (no) Heterosykliske aminoalkylpyridinderivater som psykofarmaka
DE50306277D1 (de) 4-alkyl-/4-alkenyl-/4-alkinylmethyl/-1-arylcyclohexylamin-derivate
FR2862964B1 (fr) Derives de la diphenylamine.
FR2894828B1 (fr) Nouvelles compositions cosmetologiques et/ou dermatologiques a base de derives de la proline et leurs utilisations
FR2836152B1 (fr) Compositions utiles comme detergents et leurs utilisations